ZA841584B - Liquid formulations of dihydropyridines,a process for their preparation,and their use in combating diseases - Google Patents

Liquid formulations of dihydropyridines,a process for their preparation,and their use in combating diseases

Info

Publication number
ZA841584B
ZA841584B ZA841584A ZA841584A ZA841584B ZA 841584 B ZA841584 B ZA 841584B ZA 841584 A ZA841584 A ZA 841584A ZA 841584 A ZA841584 A ZA 841584A ZA 841584 B ZA841584 B ZA 841584B
Authority
ZA
South Africa
Prior art keywords
dihydropyridines
preparation
liquid formulations
alkyl
combating diseases
Prior art date
Application number
ZA841584A
Other languages
English (en)
Inventor
Dieter Dr Hoff
Klaus-Dieter Dr Raemsch
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6192336&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA841584(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of ZA841584B publication Critical patent/ZA841584B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Pyridine Compounds (AREA)
ZA841584A 1983-03-03 1984-03-02 Liquid formulations of dihydropyridines,a process for their preparation,and their use in combating diseases ZA841584B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833307422 DE3307422A1 (de) 1983-03-03 1983-03-03 Fluessigzubereitungen von dihydropyridinen, ein verfahren zu ihrer herstellung, sowie ihre verwendung bei der bekaempfung von erkrankungen

Publications (1)

Publication Number Publication Date
ZA841584B true ZA841584B (en) 1985-06-26

Family

ID=6192336

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA841584A ZA841584B (en) 1983-03-03 1984-03-02 Liquid formulations of dihydropyridines,a process for their preparation,and their use in combating diseases

Country Status (20)

Country Link
US (1) US4537898A (no)
EP (1) EP0117888B2 (no)
JP (1) JPS59167512A (no)
KR (1) KR900004091B1 (no)
AT (1) ATE29665T1 (no)
AU (1) AU566408B2 (no)
CA (1) CA1212326A (no)
DE (2) DE3307422A1 (no)
DK (1) DK163961C (no)
ES (1) ES8503948A1 (no)
GR (1) GR79546B (no)
HK (1) HK41290A (no)
HU (1) HU194048B (no)
IE (1) IE57158B1 (no)
IL (1) IL71097A (no)
IT (1) IT1212724B (no)
NO (1) NO840770L (no)
PH (1) PH21000A (no)
PT (1) PT78149B (no)
ZA (1) ZA841584B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59222474A (ja) * 1983-06-02 1984-12-14 Teijin Ltd １，４―ジヒドロピリジン―３，５―ジカルボン酸ジエステル誘導体の製造法
JPS6038322A (ja) * 1983-08-11 1985-02-27 Fujisawa Pharmaceut Co Ltd ジヒドロピリジンａ物質含有易溶性固形製剤
US4637930A (en) * 1984-02-08 1987-01-20 Yamanouchi Pharmaceutical Co, Ltd. Transdermal formulation of nicardipine hydrochloride
JPS60246313A (ja) * 1984-05-22 1985-12-06 Yamanouchi Pharmaceut Co Ltd 塩酸ニカルジピンの注射剤およびその製法
FR2568773B1 (fr) * 1984-08-10 1989-03-03 Sandoz Lab Nouvelles compositions pharmaceutiques administrables par voie nasale
EP0175671A1 (de) † 1984-08-23 1986-03-26 Kuhlemann & Co. Pharmazeutische Zubereitung sowie Verfahren zum Darreichen dieser pharmazeutischen Zubereitung
DE3433239A1 (de) * 1984-09-11 1986-03-20 Bayer Ag, 5090 Leverkusen Feste arzneizubereitung enthaltend nitrendipin und verfahren zu ihrer herstellung
DE3581987D1 (de) * 1984-09-21 1991-04-11 Univ Iowa Res Found Immunogenische konjugate und ihre verwendung in einer dihydropyridinprobe.
US5260321A (en) * 1984-11-12 1993-11-09 Sandoz Ltd. Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
GB8428552D0 (en) * 1984-11-12 1984-12-19 Sandoz Ltd Organic compounds
GB8431119D0 (en) * 1984-12-10 1985-01-16 Fujisawa Pharmaceutical Co Anti-arteriosclerotic composition
DE3447170A1 (de) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Mischung unterschiedlicher dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
EP0188311A3 (en) * 1985-01-07 1988-07-20 Syntex (U.S.A.) Inc. Pharmaceutical formulation of nicardipine and 1,2-dioxy-omega-trialkylammonium compounds
GB2180532B (en) * 1985-09-17 1989-08-23 Inst Organicheskogo Sinteza Ak Alkoxy-and phenoxy-alkyl-esters of 2,6-dimethyl-4-(2-difluoromethoxyphenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid
AT387518B (de) * 1985-12-18 1989-02-10 Bayer Ag Verfahren zur herstellung von fluessigen spruehpraeparaten von dihydropyridinen
DE3544692A1 (de) * 1985-12-18 1987-06-19 Bayer Ag Dihydropyridinspray, verfahren zu seiner herstellung und seine pharmazeutische verwendung
EP0240484B1 (de) * 1986-03-10 1992-01-15 Kurt Dr. Burghart Pharmazeutische Zubereitung sowie Verfahren zur Herstellung derselben
US4782070A (en) * 1986-07-01 1988-11-01 Fujisawa Pharmaceutical Co., Ltd. Cerebral dysfunction therapeutic agent, which comprises a dihydropyridine compound
GB8629761D0 (en) * 1986-12-12 1987-01-21 Harris Pharma Ltd Capsules
US5001139A (en) * 1987-06-12 1991-03-19 American Cyanamid Company Enchancers for the transdermal flux of nivadipine
SE8703881D0 (sv) * 1987-10-08 1987-10-08 Haessle Ab New pharmaceutical preparation
DE3738236A1 (de) * 1987-11-11 1989-05-24 Euro Celtique Sa Beisskapsel
US5160734A (en) * 1987-11-25 1992-11-03 American Cyanamid Company Sustained release delivery system for substituted dihydropyridine calcium channel blockers
IL89049A0 (en) * 1988-01-29 1989-08-15 Merrell Dow Pharma Pharmaceutical composition containing 4-aroylimidazol-2-ones
US5478848A (en) * 1994-01-26 1995-12-26 Bayer Corporation Inhibition of arthritis by L-type calcium channel antagonists nimodipine, nisoldipine and nifedipine
HU214582B (hu) * 1994-07-26 1998-04-28 EGIS Gyógyszergyár Rt. Porlasztható, vérnyomáscsökkentő hatású gyógyszerkészítmény és eljárás előállítására
ES2133052B1 (es) * 1996-04-29 2000-05-01 Almirall Prodesfarma Sa Nuevas formulaciones farmaceuticas liquidas para la via oral.
DE10142416A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Verfahren zur Herstellung von Lösungen
DE10142417A1 (de) * 2001-08-31 2003-03-20 Molecular And Clinical Drug Re Arzneimittel
EP1933837A4 (en) * 2005-10-14 2009-07-15 Transform Pharmaceuticals Inc PHARMACEUTICAL LIQUID COMPOSITIONS OF NIMODIPIN
US20120289553A1 (en) 2009-12-28 2012-11-15 Laboratorio Reig Jofre, S.A. Oral liquid pharmaceutical composition of nifedipine
CN105168175A (zh) * 2015-08-25 2015-12-23 瑞阳制药有限公司 尼索地平胶囊及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670827C3 (de) * 1967-03-20 1974-10-24 Bayer Ag, 5090 Leverkusen 4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridin
SU432703A3 (no) * 1971-08-24 1974-06-15 Фридрих Боссерт, Вульф Фатер, Курт Бауер
DE2400819C2 (de) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
JPS5335124A (en) * 1976-09-10 1978-04-01 Nippon Denso Co Ltd Converter
EP0001247A1 (en) * 1977-09-14 1979-04-04 Kanebo, Ltd. Pharmaceutical preparation containing nifedipine and a method for producing the same.
DE2815578C2 (de) * 1978-04-11 1986-01-16 Bayer Ag, 5090 Leverkusen Neue pharmazeutische Verwendung von Nimodipin
SE429652B (sv) * 1978-06-30 1983-09-19 Haessle Ab 2.6-dimetyl-4-(2.3-diklorfenyl)-1.4-dihydropyridin-3.5-dikarboxylsyra-3-metylester-5-etylester
JPS56115726A (en) * 1980-02-20 1981-09-11 Kaken Pharmaceut Co Ltd Pharmaceutical containing nifedipine
GB2084017B (en) * 1980-09-18 1984-08-22 Sandoz Ltd Pharmaceutical compositions effective against coronary heat disease and hypertension
JPS57167911A (en) * 1981-04-09 1982-10-16 Kyoto Yakuhin Kogyo Kk Liquid pharmaceutical of nifedipine

Also Published As

Publication number Publication date
AU2520584A (en) 1984-09-06
AU566408B2 (en) 1987-10-22
IE57158B1 (en) 1992-05-20
ES530115A0 (es) 1985-04-16
IL71097A0 (en) 1984-05-31
DK108684D0 (da) 1984-02-27
HK41290A (en) 1990-06-08
CA1212326A (en) 1986-10-07
HU194048B (en) 1988-01-28
PH21000A (en) 1987-06-22
NO840770L (no) 1984-09-04
GR79546B (no) 1984-10-30
JPS59167512A (ja) 1984-09-21
PT78149B (en) 1986-05-19
IL71097A (en) 1987-09-16
EP0117888A1 (de) 1984-09-12
DK163961B (da) 1992-04-27
PT78149A (en) 1984-03-01
EP0117888B2 (de) 1992-08-26
DE3307422A1 (de) 1984-09-06
ES8503948A1 (es) 1985-04-16
KR840008278A (ko) 1984-12-14
US4537898A (en) 1985-08-27
DE3373625D1 (en) 1987-10-22
KR900004091B1 (ko) 1990-06-15
IT1212724B (it) 1989-11-30
IE840517L (en) 1984-09-03
EP0117888B1 (de) 1987-09-16
ATE29665T1 (de) 1987-10-15
DK108684A (da) 1984-09-04
JPH0460092B2 (no) 1992-09-25
DK163961C (da) 1992-09-21
IT8320301A0 (it) 1983-03-25

Similar Documents

Publication Publication Date Title
ZA841584B (en) Liquid formulations of dihydropyridines,a process for their preparation,and their use in combating diseases
HUT60734A (en) Process for producing substituted azoles and pharmaceutical compositions comprising such compounds
IL57577A0 (en) 1,2-dihydroquinolin-2-one derivatives,process for their preparation and pharmaceutical compositions containing the same
DK0598770T3 (da) Pyrazinderivater samt fremstilling og anvendelse deraf
PT74563B (en) Process for preparing benzamide derivatives and pharmaceutical compositions containing the same
HU900141D0 (en) Process for preparation of new 1,8 benzonapthridine-derivatives and for manufacturing of the pharmaceutical composition containing these compounds
DE3369983D1 (en) Isoquinoline derivatives, process for their preparation, pharmaceutical compositions containing them and their use
IL93707A0 (en) (((1,3,5-triazin-2-yl)amino-carbonyl)amino-sulfonyl)-benzoic esters,their preparation and herbicidal compositions containing them
DK27084A (da) Kompositioner aktive mod mider, mellus og thrips, farmaceutisk komposition og benzoylurinstof-forbindelser
DE3161510D1 (en) Cinnamoyl-cinnamic acid derivative, its preparation and its use as a therapeutic agent
IL65493A (en) 2-(4-benzylpiperidino)-1-(4-halophenyl)-propan-1-ol derivatives,their preparation and pharmaceutical compositions containing them
IL95608A0 (en) 1-methoxypyrimidinyl-n-nitro-phenyl-1h,1,2,4-triazole-3-sulphonamide derivatives and herbicidal compositions containing the same
EP0381508A3 (en) Use of cinnamamide for relaxing muscle tone
HUT54682A (en) Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds
IL67400A0 (en) 3,7alpha-diazacyclohepta(j,k)fluorene derivatives,their preparation and pharmaceutical compositions containing them
EG14536A (en) 2,5 dialkylphenylurea derivatives,process for their preparation herbicidal compositions containing them and method of combating weeds using them
NZ192829A (en) Use of sodium iomorinate (sodium salt of n-(3-(1'-3"oxapentamethyleneamino-ethyl-ideneamino)-2,4,6-triiodobenzoyl)-beta-amino-alpha-methyl-propionic acid as radiopaque agent in peroral rapid cholecystography